PO-0908: Inter-fraction OAR dose variation in pancreatic SBRT using contrast-enhanced in-room diagnostic CT  by Papalazarou, C. et al.
ESTRO 35  2016                                                                                                                                                  S437 
________________________________________________________________________________ 
accumulated to estimate the delivered dose after which the 
dose-volume histograms were calculated on the pCT using the 
original contours. Treatment plan adaptations applied in 
clinical practice were ignored in this analysis, assuming that 
ART does not affect anatomic changes. NTCP calculations 
were done based on the LKB model for both planned and 
delivered dose, using input parameters based on work by 
Burman et al. and Emami et al. (1,2) OAR were contoured if 
deemed at risk and subsequently peer-reviewed by a team of 
experienced head and neck radiation oncologists. The overall 
NTCP per patient was calculated by multiplication of the 
chance of no toxicity i.e.  
 
,for both the planned and delivered dose. 
 
Results: On average, 6 OAR per patient were contoured. In 8 
patients (22%), the difference in overall NTCP between 
planned and delivered dose was >3%. In half of them, NTCP of 
delivered dose was lower than planned. The largest 
difference in overall NTCP was 14% (Figure 1). The patients 
with the largest differences in overall NTCP could not be 
identified based on largest absolute dose differences for the 
OAR. Of the 8 patients that received ART clinically, 3 had an 
overall NTCP difference >3%.  
 
 
Conclusion: Differences >3% in overall NTCP between 
planned and delivered dose occur in about 1/4th of the head 
and neck cancer patients. Both increases and decreases in 
NTCP were observed, stressing the need for ART to either 
reduce NTCP or allow dose escalation. Expert opinion does 
not identify the same patients for ART as NTCP calculations 
do. A model to select patients for ART, however, should not 
only be based on changes in NTCP but should also include 
possible changes in TCP. Thus, further research is warranted 
to timely identify patients in which these differences occur, 
and on how to optimize the allocation of ART. 
1 C Burman et al, IJROBP, 1991  
2 B Emami et al, IJROBP, 1991 
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Purpose or Objective: Head and neck patients experience 
weight loss in a predictable pattern during treatment. CTV 
volumes typically reduce in volume by a third, as do the 
parotid glands. Adaptive methods for these patients focus on 
an offline protocol where the patient is rescanned and 
planned at two-to-three weeks through treatment, resulting 
in significant reduction in parotid doses. The MR linac 
(Elekta, AB, Stockholm, Sweden) will provide excellent soft 
tissue contrast which may be desirable for this group of 
patients, e.g., for tumour response monitoring. The presence 
of the magnetic field results in the Lorentz force causing 
electrons exiting the patient to spiral and be incident on the 
exit surface. This may potentially result in an increased dose 
to superficial tissues, i.e. the parotid glands. This effect can 
be controlled in plan optimisation. It is unknown, however, 
whether the presence of the magnetic field makes it 
necessary to adapt the plan at an earlier stage or more 
frequently during treatment. It is therefore the purpose of 
this paper to evaluate the effect of the magnetic field on 
need for adaptive radiotherapy in the head and neck. 
 
Material and Methods: Five patients were selected from the 
clinical archive that had shown significant weight loss during 
treatment and required a repeat CT. Both the initial planning 
CT and the repeat CT were fully contoured including spinal 
cord, brainstem, left and right parotids. An initial plan was 
created for the planning CT using Monaco, Elekta AB 
Stockholm, Sweden, which met the departmental constraints 
for OAR dose. This plan was optimised with the B field set to 
1.5T and then re-calculated at 0T, allowing the segmentation 
to remain constant. Plans were calculated with a 1% 
statistical uncertainty with the GPUMCD algorithm. The plans 
were transferred onto the re-scan CT and re-calculated. The 
magnitude of the change in dose to the OARs due to weight 
loss was compared between the 0T and 1.5T plans. 
 
Results: Table one shows the results of the analysis for the 
five initial patients investigated. Spinal cord, brainstem and 
parotid glands are included in the table. Entries in red show 
that the magnitude of change in the OAR dose is greater, 
resulting in a larger dose to that OAR compared to the 
complementary plan. The spinal cord and brainstem do not 
show a trend, with the 0T and 1.5T plans showing increase 
dose in an equal number of plans. However, for the parotid 
glands the magnitude of the change in dose is greater with 
the 1.5T field present with the majority of plans showing an 
increase. 
 
 
Conclusion: The results from these patients indicate that 
weight loss in head and neck patients results in a greater 
increase in dose to the parotid glands when treated in a 
magnetic field. Adaptive protocols for these patients 
therefore require more frequent adaption than the current 
mid-treatment approach.  
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Purpose or Objective: In SBRT for Locally Advanced 
Pancreatic Carcinoma (LAPC), the nearby organs of the GI 
tract are dose limiting. Given the daily positional variation of 
those OARs, the planning approach is conservative, often 
leading to concessions in the PTV coverage. The purpose of 
this study is to evaluate the daily variation in abdominal 
organ dose. 
 
Material and Methods: For this study, 5 patients were 
treated for LAPC with SBRT on a Cyberknife to a prescribed 
dose of 40 Gy in 5 fractions. During treatment, respiratory 
tracking was applied using implanted fiducials for real-time 
alignment of the treatment beams to the target. Planning 
constraints for the OARs included a maximum of 5 cc to 
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receive a dose above 35 Gy for the stomach, bowel and 
duodenum, and 15 Gy for the kidneys. For each patient, CT 
scans with intravenous contrast were obtained prior to the 
first three fractions using a sliding-gantry in-room CT. 
Directly after imaging, the patient was automatically 
transported by the robotic manipulator of the treatment 
couch to the treatment location in no more than 45 seconds. 
Each of the daily CTs was matched to the planning CT using 
automatic deformable image registration that allowed the 
fast (<1 min) adaptation of OAR contours to match daily 
anatomy. The OAR contours were manually adjusted by a 
radiation oncologist. To evaluate the dose to the OARs, each 
daily CT was matched to the planning CT using a combination 
of spine and fiducial matching, as performed at treatment. 
The same transformation was applied to the planned dose 
distribution, and the dose was evaluated on the new OAR 
contours. 
 
Results: For the stomach, duodenum and small bowel, we 
evaluated the maximum dose, as well as the volume 
exceeding 35 Gy. The Dmax is shown in Figure 1. In all 15 
(3x5) imaged fractions, the Dmax to at least one of these 
OARs was higher than the planned Dmax. The volume above 
35 Gy was between 0 and 0.3 cc at planning, and increased or 
remained constant during treatment. For two patients, a 
clinically significant increase was observed, i.e. to 4.7 cc for 
bowel and 4.4 cc for duodenum, respectively. However, the 
clinical constraint of 5 cc was not violated. Dose to the 
kidneys remained well within constraints. The PTV volume 
receiving 95% of prescribed dose was ≥99% for 3 of the 5 
patients. For two patients with high OAR dose at planning 
(Pt3 & Pt4), the planned coverage was 83% and 66%, resp, 
demonstrating the current limitations imposed by OAR 
constraints.
 
 
Conclusion: In this study, we have employed in-room CT, 
combined with fast deformable image registration, to 
evaluate OAR dose constraints on a daily basis. We have 
observed clinically significant differences in the maximum 
dose to critical OARs, due to anatomical variations. This 
observation, even in this small patient group, demonstrates 
the need for further research on developing adaptive 
strategies to improve CTV coverage while keeping OAR dose 
within the clinical constraints. 
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Purpose or Objective: Ion CT imaging (iCT), as obtained 
from tomographic reconstruction of ion radiographies, can be 
considered an emerging modality for adaptive radiation 
therapy (ART) in ion beam therapy due to accurate 
characterization of the in-room/in-beam anatomy in terms of 
tissue ion stopping power. The purpose of this work is to 
investigate ART feasibility, by limiting the number of low-
dose scanned beam proton radiographies obtained in the 
treatment room, for different detection configurations of list 
mode and integration mode, in combination with high 
resolution anatomical information from the initial treatment 
planning X-ray CT. 
 
Material and Methods: Proton radiographies obtained from 
Monte Carlo simulations (MCRs) are calculated based on 
patient CT images. For each pencil beam, 100 primary 
protons are delivered and the energy at the detector plane is 
converted to Water Equivalent Thickness (WET) relying on 
the Bethe-Bloch formula. List mode is reproduced by tracking 
each proton according to the Maximum Likelihood Path (MLP) 
and assigning each WET value along the estimated trajectory, 
while in integration mode only the most probable WET value 
of the raster point is assigned to a straight trajectory. To 
simulate inter-fractional anatomical changes, the patient CT, 
which is assumed to represent the in-room/in-beam scenario, 
is warped according to three-dimensional (3D) rigid and/or 
Gaussian deformation fields in head-neck and thoracic-
abdominal sites, thus leading to a modified CT (mCT), which 
provides a theoretical representation of the treatment 
planning CT. Digitally Reconstructed Radiographs of mCT 
(mDRRs) are generated and two-dimensional (2D) deformable 
and/or rigid image registration is applied between 
corresponding mDRR and MCR in projection domain. By means 
of dedicated tomographic reconstruction algorithms, which 
rely on estimating the deformation in projection domain, 
high resolution anatomical information from mDRR is merged 
with accurate tissue stopping power from MCR, thus leading 
to combined iCT-CT. In this study, the DRRs of CT are used as 
the gold standard for 2D geometrical quantification. The 
methodological framework is reported in Fig. 1. 
 
 
 
Results: Performance for list mode was slightly better than 
integration mode but for both configurations difference were 
always <35 Hounsfield Unit (HU), translating into maximum 
8% error in Relative Stopping Power (RSP), according to the 
approximate HU-RSP calibration curve. The comparison 
between list mode and integration mode as a function of 
different number of primaries will be presented, considering 
different inter-fractional anatomical changes. Quantification 
in image domain of combined iCT-CT will be performed as a 
function of different numbers of radiographies. 
 
Conclusion: Both configurations enable accurate image 
registration for ART purpose. Conclusions about achievable 
dose reduction for acceptable quality of iCT-CT will be 
drawn. 
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